Arcturus Therapeutics Ltd. Operating Income
Arcturus Therapeutics Ltd. reported Operating Income of -$6.51 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2019-05-13
- Arcturus Therapeutics Ltd. operating income (loss) for the quarter ending 2019-03-31 was -$6.51M.
- Arcturus Therapeutics Ltd. operating income (loss) for the quarter ending 2018-12-31 was -$711.00K.
- Arcturus Therapeutics Ltd. operating income (loss) for the quarter ending 2018-09-30 was -$4.36M.
- Arcturus Therapeutics Ltd. operating income (loss) for the quarter ending 2018-06-30 was -$10.07M.
- Arcturus Therapeutics Ltd. operating income (loss) for fiscal 2018 was -$21.81M.
- Arcturus Therapeutics Ltd. operating income (loss) for fiscal 2017 was -$10.49M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 71 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | -$6.51M 10-Q · filed 2019-05-13 | -$7.22M derived: sum of 2 quarters · filed 2019-05-13 | -$11.57M derived: sum of 3 quarters · filed 2019-05-13 | -$21.65M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-12-31 | -$711.00K derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | -$5.07M derived: sum of 2 quarters · filed 2019-03-18 | -$15.14M derived: sum of 3 quarters · filed 2019-03-18 | -$21.81M 10-K · filed 2019-03-18 | ||
| 2018-09-30 | -$4.36M 6-K · filed 2018-11-07 | -$14.43M derived: sum of 2 quarters · filed 2018-11-07 | -$21.10M 6-K · filed 2018-11-07 | -$26.07M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-06-30 | -$10.07M 6-K · filed 2018-11-07 | -$16.74M 6-K · filed 2018-09-28 | -$21.71M derived: sum of 3 quarters · filed 2019-05-13 | -$24.82M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-03-31 | -$6.67M 10-Q · filed 2019-05-13 | -$11.64M derived: sum of 2 quarters · filed 2019-05-13 | -$14.75M derived: sum of 3 quarters · filed 2019-05-13 | -$15.82M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2017-12-31 | -$4.97M 6-K · filed 2018-11-07 | -$8.08M derived: sum of 2 quarters · filed 2018-11-07 | -$9.15M derived: sum of 3 quarters · filed 2018-11-07 | -$10.49M 10-K · filed 2019-03-18 | ||
| 2017-09-30 | -$3.11M 6-K · filed 2018-11-07 | -$4.18M derived: sum of 2 quarters · filed 2018-11-07 | -$5.53M 6-K · filed 2018-11-07 | |||
| 2017-06-30 | -$1.07M 6-K · filed 2018-11-07 | -$2.41M 6-K · filed 2018-09-28 | ||||
| 2017-03-31 | -$1.35M 6-K · filed 2018-11-07 | |||||
| 2016-12-31 | -$1.00M 20-F · filed 2018-05-14 | -$25.17M 20-F · filed 2017-04-28 | ||||
| 2015-12-31 | -$1.91M 20-F · filed 2018-05-14 | -$19.70M 20-F · filed 2016-03-04 | ||||
| 2014-12-31 | -$33.08M 20-F · filed 2017-04-28 | |||||
| 2013-12-31 | -$10.29M 20-F · filed 2016-03-04 | -$18.10M 20-F · filed 2014-03-28 | ||||
| 2012-12-31 | -$1.50M 20-F · filed 2015-02-27 | |||||
| 2011-12-31 | -$3.91M 20-F · filed 2014-03-28 |